ZFTA Gene

Name zinc finger translocation associated
Description Predicted to be involved in negative regulation of DNA-templated transcription. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent advances in tumor biology have revealed that the gene previously designated C11orf95—now commonly known as ZFTA—plays a critical role in oncogenesis through recurrent fusion events. In particular, rare benign neoplasms such as chondroid lipomas have been found to harbor fusions between ZFTA and transcriptional co‐activators like MKL2, underscoring that aberrant ZFTA fusion events are not confined solely to malignant entities."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe oncogenic potential of ZFTA is most notably exemplified in supratentorial ependymomas, where recurrent fusions—especially with partners such as RELA, MAML2, or NCOA1/2—establish a common molecular signature. In these tumors, the presence of the ZFTA fusion transcript (e.g. ZFTA-RELA) has been shown to unify disparate histopathological entities, including cases where an ependymoma gives rise to an associated sarcomatous component, suggesting a monoclonal origin and central role of ZFTA fusions in the transformation process."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistic studies have further illuminated the function of the ZFTA moiety in these fusion proteins. By means of ChIP-seq and transcriptional analyses, researchers have discovered that the ZFTA component confers a unique DNA-binding specificity—recognizing a distinct GC-rich motif—that is crucial for driving aberrant gene expression. In the context of ZFTA-RELA fusions, this activity supports the activation of oncogenic pathways, including non-canonical NF-κB signaling, by facilitating interactions between distal regulatory elements and target gene promoters. Such insights not only refine the molecular definition of these tumors but also reveal how structural variations originating from ZFTA contribute variably to tumor differentiation and progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Uta Flucke, Bastiaan B J Tops, Nicolas de Saint Aubain Somerhausen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Presence of C11orf95-MKL2 fusion is a consistent finding in chondroid lipomas: a study of eight cases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histopathology (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/his.12100"}], "href": "https://doi.org/10.1111/his.12100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23672313"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23672313"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "David Cachia, Khalida Wani, Marta Penas-Prado, et al. "}, {"type": "b", "children": [{"type": "t", "text": "C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Tumor Pathol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10014-014-0205-1"}], "href": "https://doi.org/10.1007/s10014-014-0205-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25388523"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25388523"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Sho Tamai, Yoshiko Nakano, Masashi Kinoshita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Tumor Pathol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10014-020-00388-6"}], "href": "https://doi.org/10.1007/s10014-020-00388-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33221956"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33221956"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ran Tomomasa, Yasuhito Arai, Reika Kawabata-Iwakawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Pathol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bpa.12943"}], "href": "https://doi.org/10.1111/bpa.12943"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33576087"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33576087"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Tatsuya Ozawa, Syuzo Kaneko, Frank Szulzewsky, et al. "}, {"type": "b", "children": [{"type": "t", "text": "C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40478-021-01135-4"}], "href": "https://doi.org/10.1186/s40478-021-01135-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33685520"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33685520"}]}]}]}
NCBI Gene ID 65998
API
Download Associations
Predicted Functions View ZFTA's ARCHS4 Predicted Functions.
Co-expressed Genes View ZFTA's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View ZFTA's ARCHS4 Predicted Functions.

Functional Associations

ZFTA has 1,259 functional associations with biological entities spanning 4 categories (chemical, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 11 datasets.

Click the + buttons to view associations for ZFTA from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of ZFTA gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of ZFTA gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CellMarker Gene-Cell Type Associations cell types associated with ZFTA gene from the CellMarker Gene-Cell Type Associations dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of ZFTA gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
GO Biological Process Annotations 2025 biological processes involving ZFTA gene from the curated GO Biological Process Annotations2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of ZFTA gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of ZFTA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of ZFTA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of ZFTA gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of ZFTA gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of ZFTA gene from the RummaGEO Gene Perturbation Signatures dataset.